SI2991976T1 - Sintheza 3-(5-amino-2-metil-4-oksokvinazolin-3(4H)-il)piperidin-2,6- diona - Google Patents

Sintheza 3-(5-amino-2-metil-4-oksokvinazolin-3(4H)-il)piperidin-2,6- diona

Info

Publication number
SI2991976T1
SI2991976T1 SI201430431T SI201430431T SI2991976T1 SI 2991976 T1 SI2991976 T1 SI 2991976T1 SI 201430431 T SI201430431 T SI 201430431T SI 201430431 T SI201430431 T SI 201430431T SI 2991976 T1 SI2991976 T1 SI 2991976T1
Authority
SI
Slovenia
Prior art keywords
oxoquinazolin
dione
piperidine
synthesis
amino
Prior art date
Application number
SI201430431T
Other languages
English (en)
Slovenian (sl)
Inventor
Alexander L. Ruchelman
Benjamin M. Cohen
Anusuya Choudhury
Matthew M. Kreilein
William W. Leong
Hon-Wah Man
Original Assignee
Celgene Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corporation filed Critical Celgene Corporation
Publication of SI2991976T1 publication Critical patent/SI2991976T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SI201430431T 2013-05-01 2014-04-30 Sintheza 3-(5-amino-2-metil-4-oksokvinazolin-3(4H)-il)piperidin-2,6- diona SI2991976T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361818254P 2013-05-01 2013-05-01
PCT/US2014/036083 WO2014179416A1 (en) 2013-05-01 2014-04-30 Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione
EP14728381.6A EP2991976B1 (en) 2013-05-01 2014-04-30 Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione

Publications (1)

Publication Number Publication Date
SI2991976T1 true SI2991976T1 (sl) 2017-11-30

Family

ID=50885008

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201430431T SI2991976T1 (sl) 2013-05-01 2014-04-30 Sintheza 3-(5-amino-2-metil-4-oksokvinazolin-3(4H)-il)piperidin-2,6- diona

Country Status (26)

Country Link
US (3) US9067912B2 (enExample)
EP (2) EP3199532A1 (enExample)
JP (2) JP6490055B2 (enExample)
KR (1) KR20160003228A (enExample)
CN (2) CN105377831B (enExample)
AR (1) AR096165A1 (enExample)
AU (2) AU2014260011A1 (enExample)
CA (1) CA2910971A1 (enExample)
CY (1) CY1119525T1 (enExample)
DK (1) DK2991976T3 (enExample)
ES (1) ES2645944T3 (enExample)
HR (1) HRP20171535T1 (enExample)
HU (1) HUE034770T2 (enExample)
LT (1) LT2991976T (enExample)
MX (1) MX363652B (enExample)
NZ (1) NZ628322A (enExample)
PH (1) PH12015502477A1 (enExample)
PL (1) PL2991976T3 (enExample)
PT (1) PT2991976T (enExample)
RS (1) RS56565B1 (enExample)
RU (1) RU2015151359A (enExample)
SG (1) SG11201508836XA (enExample)
SI (1) SI2991976T1 (enExample)
SM (1) SMT201700513T1 (enExample)
TW (1) TW201536766A (enExample)
WO (1) WO2014179416A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS52349B (sr) 2006-09-26 2012-12-31 Celgene Corporation 5-supstituisani derivati hinazolinona kao antitumorski agensi
CA2829570C (en) 2011-03-11 2019-05-07 Celgene Corporation Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
EP2892887B1 (en) 2012-09-04 2020-07-15 Celgene Corporation Isotopologues of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2-6-dione and methods of preparation thereof
US10973822B2 (en) 2015-07-02 2021-04-13 Celgene Corporation Combination therapy for treatment of hematological cancers and solid tumors
CN106083622B (zh) * 2016-06-16 2018-06-19 常州齐晖药业有限公司 一种甲苯咪唑中间体3,4-二氨基二苯甲酮的制备方法
US20180258064A1 (en) * 2017-03-07 2018-09-13 Celgene Corporation Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
CN113101295A (zh) * 2020-03-20 2021-07-13 上海疆云医疗健康科技有限公司 二苯乙烯类似物在治疗糖尿病肾脏疾病中的用途
KR20240055046A (ko) * 2021-09-02 2024-04-26 신톤 비.브이. 오시머티닙을 제조하는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2032538A2 (en) * 2006-06-08 2009-03-11 Array Biopharma, Inc. Quinoline compounds and methods of use
RS52349B (sr) * 2006-09-26 2012-12-31 Celgene Corporation 5-supstituisani derivati hinazolinona kao antitumorski agensi
RU2017120977A (ru) * 2011-03-11 2018-11-15 Селджин Корпорейшн Способ лечения рака с использованием 3-(5-амино-2-метил-4-оксо-4h-хиназолин-3-ил)пиперидин-2,6-диона
CA2829570C (en) * 2011-03-11 2019-05-07 Celgene Corporation Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
EP2892887B1 (en) * 2012-09-04 2020-07-15 Celgene Corporation Isotopologues of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2-6-dione and methods of preparation thereof
EP2943201B2 (en) * 2013-01-14 2020-07-29 Deuterx, LLC 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives

Also Published As

Publication number Publication date
RS56565B1 (sr) 2018-02-28
NZ628322A (en) 2017-06-30
CN107935994A (zh) 2018-04-20
US9303014B2 (en) 2016-04-05
CN105377831B (zh) 2018-02-02
KR20160003228A (ko) 2016-01-08
JP6490055B2 (ja) 2019-03-27
RU2015151359A (ru) 2017-06-06
MX2015015073A (es) 2016-03-03
EP2991976A1 (en) 2016-03-09
LT2991976T (lt) 2017-10-25
CA2910971A1 (en) 2014-11-06
CN105377831A (zh) 2016-03-02
JP2019069958A (ja) 2019-05-09
SMT201700513T1 (it) 2018-01-11
US20150274694A1 (en) 2015-10-01
US9067912B2 (en) 2015-06-30
US9266858B2 (en) 2016-02-23
PH12015502477A1 (en) 2016-02-22
MX363652B (es) 2019-03-28
AR096165A1 (es) 2015-12-09
ES2645944T3 (es) 2017-12-11
WO2014179416A1 (en) 2014-11-06
US20140330016A1 (en) 2014-11-06
EP3199532A1 (en) 2017-08-02
HUE034770T2 (hu) 2018-02-28
PT2991976T (pt) 2017-11-14
CY1119525T1 (el) 2018-03-07
HRP20171535T1 (hr) 2017-11-17
EP2991976B1 (en) 2017-09-20
PL2991976T3 (pl) 2018-01-31
SG11201508836XA (en) 2015-11-27
US20160009685A1 (en) 2016-01-14
JP2016517886A (ja) 2016-06-20
TW201536766A (zh) 2015-10-01
AU2017200965A1 (en) 2017-03-02
DK2991976T3 (da) 2017-11-06
AU2014260011A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
EP2943201A4 (en) 3- (5-SUBSTITUTED 4-OXOCHINAZOLIN-3 (4H) -YL) -3-DEUTERO-PIPERIDINE-2,6-DION DERIVATIVES
IL239563A0 (en) Derivatives of -n(converted)-5-fluoro-4-imino-3-methyl-2-oxo-4,3-dihydropyrimidine-1 (h2)-carboxamides
IL243268A0 (en) Aids for positioning the heads of premature babies
SG11201405129RA (en) Pyrazolo - triazine derivatives as selective cyclin- dependent kinase inhinitors
SG11201508836XA (en) Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione
EP2831080A4 (en) LACTAMES INHIBITORS OF KINASES
IL244315B (en) Spirocyclic compounds as tryptophan hydroxylase inhibitors
GB201303109D0 (en) Novel pyrimidine compounds
ZA201407828B (en) Bicyclic pyrazinone derivatives
IL244494B (en) Formulations of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindoline-2-yl)piperidine-6,2-dione
IL236057A0 (en) 4,2,1-triazine-6-carboxamide kinase inhibitors
IL239561B (en) Derivatives of n-(converted)-5-fluoro-4-imino-3-methyl-2-oxo-4,3-dihydropyrimidine-1(2h)-carboxylate
ZA201406777B (en) 3,5-diaminopyrazole kinase inhibitors
IL259597A (en) Cycling therapy using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
HUP1500480A2 (en) Reform flute head
TH1501006617A (th) การสังเคราะห์ 3-(5อะมิโน-2-เมธิล-4-ออกโซควินาโซลิน-3(4h)-อิล)ไพเพอริดีน-2,6-ไดโอน
GB201304811D0 (en) Novel treatment for hypertension
GB201300649D0 (en) Cyclization